These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 16306535)

  • 1. Mitochondrial toxicity associated with linezolid.
    Soriano A; Miró O; Mensa J
    N Engl J Med; 2005 Nov; 353(21):2305-6. PubMed ID: 16306535
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prosthetic joint and orthopedic implant infections: side effects of linezolid in prolonged therapy].
    Salinas-Botrán A; Moreno-Parrado L; Vicente-Romero M; Martínez-Alfaro E
    Enferm Infecc Microbiol Clin; 2010; 28(6):394-6. PubMed ID: 20096970
    [No Abstract]   [Full Text] [Related]  

  • 3. Severe bilateral optic neuritis associated with prolonged linezolid therapy.
    Frippiat F; Bergiers C; Michel C; Dujardin JP; Derue G
    J Antimicrob Chemother; 2004 Jun; 53(6):1114-5. PubMed ID: 15117929
    [No Abstract]   [Full Text] [Related]  

  • 4. Linezolid for the treatment of serious gram-positive infections.
    McAuley L
    Issues Emerg Health Technol; 2001 Mar; (15):1-6. PubMed ID: 11902223
    [No Abstract]   [Full Text] [Related]  

  • 5. Safety and tolerability of linezolid in children.
    Saiman L; Goldfarb J; Kaplan SA; Wible K; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
    Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S193-200. PubMed ID: 14520146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of linezolid for Gram-positive orthopedic infections: a prospective case series.
    Rao N; Hamilton CW
    Diagn Microbiol Infect Dis; 2007 Oct; 59(2):173-9. PubMed ID: 17574788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Good clinical outcomes but high rates of adverse reactions during linezolid therapy for serious infections: a proposed protocol for monitoring therapy in complex patients.
    Bishop E; Melvani S; Howden BP; Charles PG; Grayson ML
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1599-602. PubMed ID: 16569895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of linezolid in children. Introduction.
    Kaplan SL
    Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S151-2. PubMed ID: 14520139
    [No Abstract]   [Full Text] [Related]  

  • 9. Linezolid-associated toxic optic neuropathy.
    Rucker JC; Hamilton SR; Bardenstein D; Isada CM; Lee MS
    Neurology; 2006 Feb; 66(4):595-8. PubMed ID: 16505322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linezolid-induced hyperlactatemia in a burn patient.
    Esnault P; Cotte J; Cungi PJ; Romanat PE; Boret H
    Ann Fr Anesth Reanim; 2013 Sep; 32(9):e117-8. PubMed ID: 23948021
    [No Abstract]   [Full Text] [Related]  

  • 11. Linezolid-induced angioedema and urticaria in a patient with renal failure.
    Yang M; Xu M
    Braz J Infect Dis; 2012; 16(6):606-7. PubMed ID: 23141989
    [No Abstract]   [Full Text] [Related]  

  • 12. Similar hematologic effects of long-term linezolid and vancomycin therapy in a prospective observational study of patients with orthopedic infections.
    Rao N; Ziran BH; Wagener MM; Santa ER; Yu VL
    Clin Infect Dis; 2004 Apr; 38(8):1058-64. PubMed ID: 15095207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sideroblastic anemia due to linezolid in a patient with a left ventricular assist device.
    Montpetit MC; Shammo JL; Loew J; Dunlap S; Pamboukian SV; Heroux A
    J Heart Lung Transplant; 2004 Sep; 23(9):1119-22. PubMed ID: 15454180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The first clinical experiences in Hungary with a new effective antibiotic (linezolid) effective against Gram-positive infections].
    Pulay I; Konkoly TM; Zsirka KA; Csapó Z; Flautner L; Tihanyi T
    Orv Hetil; 2003 Jan; 144(1):29-33. PubMed ID: 12635350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy and tolerability of linezolid therapy in the treatment of orthopedic implant infections caused by gram-positive multiresistant cocci].
    Jover-Diaz F; Talents A; Alcalá-Santaella R; Cuadrado JM; Olmedo N; Gazquez C
    Rev Clin Esp; 2010 Mar; 210(3):145-6. PubMed ID: 20167313
    [No Abstract]   [Full Text] [Related]  

  • 16. Linezolid versus vancomycin in the treatment of known or suspected resistant gram-positive infections in neonates.
    Deville JG; Adler S; Azimi PH; Jantausch BA; Morfin MR; Beltran S; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
    Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S158-63. PubMed ID: 14520141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linezolid for the treatment of children with bacteremia or nosocomial pneumonia caused by resistant gram-positive bacterial pathogens.
    Jantausch BA; Deville J; Adler S; Morfin MR; Lopez P; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
    Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S164-71. PubMed ID: 14520142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe lactic acidosis associated with linezolid use in a patient with the mitochondrial DNA A2706G polymorphism.
    Carson J; Cerda J; Chae JH; Hirano M; Maggiore P
    Pharmacotherapy; 2007 May; 27(5):771-4. PubMed ID: 17461714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linezolid for the treatment of complicated skin and skin structure infections in children.
    Yogev R; Patterson LE; Kaplan SL; Adler S; Morfin MR; Martin A; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
    Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S172-7. PubMed ID: 14520143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversible inhibition of mitochondrial protein synthesis during linezolid-related hyperlactatemia.
    Garrabou G; Soriano A; López S; Guallar JP; Giralt M; Villarroya F; Martínez JA; Casademont J; Cardellach F; Mensa J; Miró O
    Antimicrob Agents Chemother; 2007 Mar; 51(3):962-7. PubMed ID: 17194826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.